InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Wilbur James. Officer active across 1 company, notably 10x Genomics, Inc.. Cumulatively, 6 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €1.1m. History available since 14 September 2022. The latest transaction was disclosed on 22 November 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Wilbur James is a declarant linked to 10x Genomics, Inc., where he is Chief Commercial Officer. He has 6 filings in total, and across the 6 recent filings covered, they relate to sales between 2022-09-16 and 2023-11-27, with total sales of EUR 1130997 and no purchases indicated.